Company: SMNR
Filing Date: 2025-10-21
Form Type: S-1
Source: 0001193125-25-245178
Chunk: 292

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-10-21
Form: S-1
Chunk 292
---
ary duty. They may also reduce the likelihood of derivative litigation against Semnur’s directors and officers, even though 188

an action, if successful, might benefit Semnur and its stockholders. In addition, a stockholder’s investment may be adversely affected to the extent Semnur pay the costs of settlement and damage awards against directors and officers pursuant to these indemnification provisions. Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors or executive officers, Semnur has been informed that in the opinion of the SEC, such indemnification is against public policy and is therefore unenforceable. At present, there is no pending litigation or proceeding involving any of Semnur’s or Semnur’s directors or executive officers as to which indemnification is required or permitted, and Semnur and Semnur are not aware of any threatened litigation or proceeding that may result in a claim for indemnification.

<div align='center'>189</div>

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT The following table sets forth information regarding the beneficial ownership of our Common Stock as of October 6, 2025 by:

| • |     | each person or “group” known to be the beneficial owner of more than 5% of our outstanding Common Stock; |

| • |     | each of our named executive officers and directors; and |

| • |     | all of our executive officers and directors as a group. |

Beneficial ownership is determined according to the rules of the SEC, which generally provide that a person has beneficial ownership of a security if he, she or it possesses sole or shared voting or investment power over that security, including options and warrants that are currently exercisable or exercisable within 60 days. Shares subject to options and warrants that are currently exercisable or exercisable within 60 days of October 6, 2025 are considered outstanding and beneficially owned by the person holding such options or warrants for the purpose of computing the percentage ownership of that person, but are not treated as outstanding for the purpose of computing the percentage ownership of any other person. The beneficial ownership of our Common Stock is based on 229,740,978 shares of such Common Stock outstanding as of October 6, 2025. Voting power is based on 229,740,978 shares of Common Stock and 5,423,606 shares of Series A Preferred Stock outstanding as October 6, 2025. Shares of Series A Preferred Stock